For example, Lysine Demethylase 5B (KDM5B), a potentially novel E3 ligase is highly expressed in breast cancer at both transcriptomics and proteomics, and 98.8% (2448/2478) of cells expressing KDM5B are malignant cells in breast cancer (Fig. 3c). This evidence concerns the gene KDM5B and breast carcinoma.